Terms: = Brain cancer AND AFF1, MLLT2, 4299, ENSG00000172493, P51825, AF-4, PBM1
9 results:
1. KMT2A-D pathogenicity, prevalence, and variation according to a population database.
Larson JK; Hunter-Schlichting DN; Crowgey EL; Mills LJ; Druley TE; Marcotte EL
Cancer Med; 2023 Mar; 12(6):7234-7245. PubMed ID: 36479909
[TBL] [Abstract] [Full Text] [Related]
2. Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study.
Chua W; Law JP; Cardoso VR; Purmah Y; Neculau G; Jawad-Ul-Qamar M; Russell K; Turner A; Tull SP; Nehaj F; Brady P; Kastner P; Ziegler A; Gkoutos GV; Pavlovic D; Ferro CJ; Kirchhof P; Fabritz L
PLoS Med; 2021 Feb; 18(2):e1003405. PubMed ID: 33534825
[TBL] [Abstract] [Full Text] [Related]
3. Clinical Evaluation of Massively Parallel RNA Sequencing for Detecting Recurrent Gene Fusions in Hematologic Malignancies.
Kim B; Lee H; Shin S; Lee ST; Choi JR
J Mol Diagn; 2019 Jan; 21(1):163-170. PubMed ID: 30347268
[TBL] [Abstract] [Full Text] [Related]
4. Clinical impact of intraoperative CCEP monitoring in evaluating the dorsal language white matter pathway.
Yamao Y; Suzuki K; Kunieda T; Matsumoto R; Arakawa Y; Nakae T; Nishida S; Inano R; Shibata S; Shimotake A; Kikuchi T; Sawamoto N; Mikuni N; Ikeda A; Fukuyama H; Miyamoto S
Hum Brain Mapp; 2017 Apr; 38(4):1977-1991. PubMed ID: 28112455
[TBL] [Abstract] [Full Text] [Related]
5. Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis.
Takahashi I; Hama Y; Matsushima M; Hirotani M; Kano T; Hohzen H; Yabe I; Utsumi J; Sasaki H
Mol Brain; 2015 Oct; 8(1):67. PubMed ID: 26497046
[TBL] [Abstract] [Full Text] [Related]
6. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.
Reifenberger G; Ichimura K; Reifenberger J; Elkahloun AG; Meltzer PS; Collins VP
Cancer Res; 1996 Nov; 56(22):5141-5. PubMed ID: 8912848
[TBL] [Abstract] [Full Text] [Related]
7. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer.
Wick W; Petersen I; Schmutzler RK; Wolfarth B; Lenartz D; Bierhoff E; Hümmerich J; Müller DJ; Stangl AP; Schramm J; Wiestler OD; von Deimling A
Oncogene; 1996 Mar; 12(5):973-8. PubMed ID: 8649814
[TBL] [Abstract] [Full Text] [Related]
8. Laf-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to af-4, the gene fused to MLL in t(4;11) leukemias.
Ma C; Staudt LM
Blood; 1996 Jan; 87(2):734-45. PubMed ID: 8555498
[TBL] [Abstract] [Full Text] [Related]
9. Combination chemotherapy of limited-stage small-cell lung cancer. A controlled trial on 221 patients comparing two alternating regimens.
Osterlind K; Hansen M; Hirsch FR; Dombernowsky P; Sörenson S; Pedersen AG; Hansen HH
Ann Oncol; 1991 Jan; 2(1):41-6. PubMed ID: 1848996
[TBL] [Abstract] [Full Text] [Related]
